Why screen for cystic fibrosis? A clinician's view

Acta Paediatrica, International Journal of Paediatrics, Supplement

Volumn 88, Issue 432, 1999, Pages 28-32

  Dodge, J A ^a  

^a SINGLETON HOSPITAL   (United Kingdom)

Author keywords

Cystic fibrosis; Doctor parent relationship; Lung damage; Morbidity; New therapies; Survival

Indexed keywords

CONFERENCE PAPER; COST BENEFIT ANALYSIS; CYSTIC FIBROSIS; DOCTOR PATIENT RELATION; EARLY DIAGNOSIS; HUMAN; LUNG INJURY; MORBIDITY; NEWBORN; NEWBORN SCREENING; PRIORITY JOURNAL; SURVIVAL; TREATMENT PLANNING;

EID: 0033429011     PISSN: 08035326     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1651-2227.1999.tb01152.x     Document Type: Conference Paper

References (26)

1. 1. Crossley JR, Elliot RB, Smith PA. Dried blood spot screening for cystic fibrosis in the newborn. Lancet 1979; 1: 472-4
2. 2. Wilson JMG, Jungner G. Principles and practice of screening for disease. Geneva: WHO 1968
3. 3. Corey M. Requirements for assessing possible benefits of screening: fundamental problems of comparing screened and unscreened groups of cystic fibrosis patients. In: Travert G, Wursteisen B, editors. Neonatal Screening for Cystic Fibrosis. Proceedings of the International Conference, Caen, September 10-11, 1998. Caen Cedex: Presses Universitaires de Caen, 1999: 289-99
4. 4. Farrell PM, Kosovok MR, Rock MJ, et al. Assessment of the benefits, risks and costs of cystic fibrosis screening in Wisconsin, USA. In: Travert G, Wursteisen B, editors. Neonatal Screening for Cystic Fibrosis. Proceedings of the International Conference, Caen, September 10-11, 1998. Caen Cedex: Presses Universitaires de Caen, 1999: 239-53
5. 5. Chatfield S, Owen G, Ryley HC, et al. Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after five years of screening. Arch Dis Child 1991; 66: 29-33
6. 6. Dankert-Roelse JE, te Meerman GJ, Martijn A, et al. Survival and clinical outcome in patients with cystic fibrosis with or without neonatal screening. J Pediatr 1989; 114: 362-7
7. 7. Dankert-Roelse JE, te Meerman GJ. Long-term prognosis of patients with cystic fibrosis in relation to early detection by neonatal screening in a cystic fibrosis centre. Thorax 1995; 50: 712-8
8. 8. Waters DL, Wilcken B, Irwig L, et al. Clinical outcomes of newborn screening for cystic fibrosis. Arch Dis Child Fetal Neonatal Ed. 1999; 80: F1-F7
9. 9. Mastella G, Barlocco EG, Antonacci B, et al. Is neonatal screening for cystic fibrosis advantageous? The answer of a wide 15 years follow-up study. In: Travert G, editor Mucovisidose: Dépistage Neonatal et Prise en Charge. Précoce. Caen: CHRU de Caen, 1988: 127-43
10. 10. Farrell PM, Kosorok M, Laxova A, et al. Nutritional benefits of neonatal screening for cystic fibrosis. N Engl J Med 1997; 387: 963-9
11. 11. Turck D, Grosskopf C, Mouterde O, et al. Current health status of the CF patients identified by neonatal screening in France. Data from the European registry of cystic fibrosis (ERCF). In: Travert G, Wursteisen B, editors. Neonatal Screening for Cystic Fibrosis. Proceedings of the International Conference, Caen, September 10-11, 1998. Caen Cedex: Presses Universitaires de Caen, 1999: 263
12. 12. Wilcken B, Chalmers G. Reduced morbidity in patients with cystic fibrosis detected by neonatal screening. Lancet 1985: 8468
13. 13. Feingold J, Guilloud-Bataille M, de Crozes D. Neonatal screening for Cystic Fibrosis in France: possible reduced morbidity in detected patients. In: Travert G, Wursteisen B, editors. Neonatal Screening for Cystic Fibrosis. Proceedings of the International Conference, Caen, September 10-11, 1998. Caen Cedex: Presses Universitaires de Caen, 1999: 275
14. 14. Nielsen OH, Schiøtz PO. Cystic fibrosis in Denmark in the period 1945-1981: evaluation of centralised treatment. Acta Paediatr Scand 1982; 301 Suppl: 107-19
15. 15. Frederiksen B, Koch C, Høiby N. Antibiotic treatment at time of initial colonisation with Pseudomonas aeruginosa postpones chronic infection and prevents deterioration in pulmonary function in patients with cystic fibrosis. Isr J Med Sci 1996; 32: 5170
16. 16. British Paediatric Association Working Party on Cystic Fibrosis. Cystic fibrosis in the United Kingdom 1977-85: an improving picture. Br Med J 1998; 297: 1599-16
17. 17. Mérelle ME, te Meerman GJ, Dankert-Roelse JE. The influence of treatment at a specialised centre on the course of the disease in patients with cystic fibrosis. In: Travert G, Wursteisen B, editors. Neonatal Screening for Cystic Fibrosis. Proceedings of the International Conference, Caen, September 10-11, 1998. Caen Cedex: Presses Universitaires de Caen, 1999: 301
18. 18. Mahadeva R, Webb K, Westerbeck RC, et al. Clinical outcome in relation to care in centres specialising in cystic fibrosis: cross sectional study. Br Med J 1998; 316: 1771-5
19. 19. Walters S, Britton J, Hodson ME. Hospital care for adults with cystic fibrosis: an overview and comparison between special cystic fibrosis clinics and general clinics using a patient questionnaire. Thorax 1994; 49: 300-6
20. 20. Armstrong DS, Grimwood K, Carzino K, et al. Lower respiratory tract infection and inflammation in infants with newly diagnosed cystic fibrosis. Br Med J 1995; 310: 1571-2
21. 21. Procopio E, Taccetti G, Campana S, et al. The effect of neonatal screening for cystic fibrosis on the nutritional status. 4th Meeting of the International Society for Neonatal Screening, Stockholm, 1999
22. 22. Szymborski J, Bal J, Szumska A. Neonatal screening test for cystic fibrosis in Poland. 4th Meeting of the International Society for Neonatal Screening, Stockholm, 1999
23. 23. Al-Jader LN, Goodchild MC, Ryley HC, Harper PS. Attitudes of parents of cystic fibrosis children towards neonatal screening and antenatal diagnosis. Clin Genet 1990; 38: 460-5
24. 24. Helton JL, Harmon RJ, Robinson N, Accurso FJ. Parental attitudes towards newborn screening for cystic fibrosis. Pediatr Pulmonol 1991; Suppl 7: 23-8
25. 25. Pollitt R. Director of Trent Metabolic Neonatal Screening Programme. Quoted in Br Med J 1997; 315: 901
26. 26. Phelan PD. Neonatal screening for cystic fibrosis (Editorial). Thorax 1995; 50: 705-6